RECAP ESMO 2026 — 117 trials, 1,732 results slides and physician reactions, all in one place See ESMO 2026 results →
Charu Aggarwal, MD, MPH, FASCO profile photo
KOL Pulse Profile · 2026

Charu Aggarwal, MD, MPH, FASCO

Leslye M. Heisler Professor for Lung Cancer Excellence · Penn Medicine Abramson Cancer Center · Institution profile ↗

Leslye M. Heisler Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | #CCC Chair @ASCO | Tweets my own | COI: https://t.co/ghKU8KhBvl

Charu Aggarwal, MD, MPH, FASCO (@CharuAggarwalMD) ranks #29 among US lung cancer KOLs on X in 2026, by engagement from fellow physicians. 6 physicians shared, quoted or replied to their posts this year. CMS Open Payments lists $78,277 in 2025 general payments.

Charu Aggarwal, MD, MPH, FASCO, Top 50 lung cancer KOL in the USA, KOL Pulse 2026 rankings
Charu Aggarwal, MD, MPH, FASCO, Top 50 lung cancer KOL in the USA, KOL Pulse 2026 rankings

At a Glance

This Month

What Charu Aggarwal, MD, MPH, FASCO has posted in the last 30 days. Updated November 10, 2026.

No trial posts in the last 30 days.

2026 Rankings

ListUS rankGlobal rankPhysicians engagedPhysician engagements
Lung Cancer#29—612Full ranking

From the Podium, 2025–26

Talks, posters and sessions Charu Aggarwal, MD, MPH, FASCO presented at SABCS 2025 and 2026 meetings, each confirmed by a public source.

What Colleagues Are Saying About Charu Aggarwal, MD, MPH, FASCO

2026 posts by fellow physicians that mention @CharuAggarwalMD, quoted word for word.

🔥🚨@OncoAlert Hot off the press. Just published @ASCOPost Evening News: ⭐️#SundayEdition discussion, featuring two GREAT #Experts/Colleagues Drs @CharuAggarwalMD & Jonathan Goldman on: ‼️Major #Research/#Data Highlights, from @IASLC #WCLC26, in: ❇️#TargetedTherapy for Non-Small Cell #LungCancer. 👇🏻 https://t.co/MSo7NLw5Tw
Rami Manochakian MD, FASCO (@RManochakian) · · View on X ↗
Arriving to Beautiful Seoul & could not resist walking right away to #Starfield_Library & walking with @CharuAggarwalMD Thank you @IASLC for making the world come together #WCLC26 https://t.co/8n7YlfwMR1
Dr. Nagla Abdel Karim (@NaglaAKarimMD) · · View on X ↗
#WCLC26 👏👏Congrats @CharuAggarwalMD @UPennCancer for your excellent @IASLC Daniel Ihde Lectureship Award #womeninthoraciconcology https://t.co/6qyeyfeNON
Dr. Estela Rodriguez (@Latinamd) · · View on X ↗
Big congratulations to Dr. @CharuAggarwalMD - winner of the #WCLC26 Daniel Ihde Lectureship Award for Medical Oncology. So well deserved! https://t.co/5a9YJfoHbC
Stephen V Liu, MD (@StephenVLiu) · · View on X ↗
Thanks Kevin, excellent thought and yes this is an under appreciated aspect of cancer care. Also effects on sleep, exercise, diet under appreciated. The lung cancer doctors are an impressive group. I’m sure they’ll educate us both. @CharuAggarwalMD @FionnualaCrowle @FordePatrick @GlopesMd @FordePatrick @BalazsHalmosMD and many more Doing a great job with a lot of heart and Seoul this week
Simon C (@scserendipity1) · · View on X ↗

Charu Aggarwal, MD, MPH, FASCO’s Presentations

Slides from Charu Aggarwal, MD, MPH, FASCO’s 2026 presentations, as shared by physicians in the audience.

Slide from Charu Aggarwal, MD, MPH, FASCO presentation, shared by Christian RolfoSlide from Charu Aggarwal, MD, MPH, FASCO presentation, shared by Christian RolfoSlide from Charu Aggarwal, MD, MPH, FASCO presentation, shared by Christian Rolfo
@CharuAggarwalMD presenting at #WCLC26 interesting data on tumor informed MRD ctDNA in early NSCLC in a large cohort emphasizing the role as prognostic factor @isliquidbiopsy @IASLC https://t.co/VUKJ6ttkJZ
Christian Rolfo (@christianrolfo) · · View on X ↗

Industry Payments

CMS Open Payments · 2025 general payments
$78,277 across 42 payments
View the CMS record ↗
Free Access · KOL Pulse Intelligence

Track oncology’s top KOLs in your specialty

Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:

  • ✓Enhanced KOL profiles
  • ✓Pharma influence & potential advisory-board patterns
  • ✓2025 Open Payments financial analysis
  • ✓Social-media sentiment & trend signals
Get free access — pick your specialty
Choose the tumor types you follow. No cost, unsubscribe anytime.

FAQ

How does Charu Aggarwal, MD, MPH, FASCO rank among oncology KOLs in 2026?

Charu Aggarwal, MD, MPH, FASCO ranks #29 among US lung cancer KOLs on X in 2026, based on engagement from fellow physicians (KOL Pulse rankings, updated November 10, 2026).

What did Charu Aggarwal, MD, MPH, FASCO present at oncology meetings in 2026?

WCLC 2026 (abstract presentation): Tumor-informed MRD ctDNA in early NSCLC in a large cohort (prognostic role).

Does Charu Aggarwal, MD, MPH, FASCO receive industry payments?

CMS Open Payments lists $78,277 in 2025 general payments. Source: CMS Open Payments, program year 2025.

See something wrong? Report an issue with this profile.

KOL Pulse analysis · Reviewed by Brian Shields, Founder, KOL Pulse · Updated